Wuhan EasyDiagnosis Biomedicine Co., Ltd of Wuhan, Hubei at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Wuhan EasyDiagnosis Biomedicine Co., Ltd

No. 388, Gaoxin 2nd rd East Lake Hi-Tech Development Zone, 430074 Wuhan, Hubei
Telephone +86 27 87808955
Fax +86 27 87808005

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.


Abby Yang

Global Marketing Manager
Overseas Sales Department

+86 13507134344


Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our products

Product category: Diagnostic rapid tests

COVID-19 (SARS-CoV-2) Nucleic Acid Test Kit

[Product name] COVID-19 (SARS-CoV-2) Nucleic Acid Test Kit

[Intended use] COVID-19 SARS-CoV-2 Nucleic Acid Test Kit is a real-time RT-PCR test kit, intended for the qualitative detection of nucleic acid from the SARS-CoV-2, in upper and lower respiratory tract specimens (such as oropharyngeal swabs, nasopharyngeal swabs and sputum).

[Storage conditions and Validity] 6 months at -20±5℃

[Instruments applied] ABI7500 (Thermo Fisher), LightCycler480 (Roche) and other quantitative fluorescence PCR platforms with FAM, HEX and ROX fluorescence detection channel.

More Less

Product category: Diagnostic rapid tests

Nucleic Acid Extraction Reagent

[Product name] Nucleic Acid Extraction Reagent

[Intended use] For nucleic acid extraction, enrichment, purification and other steps. The treated products are used for clinical in vitro testing. 
[Storage conditions and shelf life] It can be stored under dry conditions at room temperature (15~25℃ ) for 12 months. The period of validity may be prolonged at 2~8℃ . Protease K and Carrier RNA are stored at - 20±5℃ after the dissolution and should avoid repeated freezing and thawing.


More Less

Product category: Diagnostic rapid tests

COVID-19 (SARS-CoV-2) IgM/IgG Antibody Test Kit

[Product name] COVID-19 (SARS-CoV-2) IgM/IgG Antibody Test Kit

[Intended use] This kit is used for the qualitative detection of 2019-nCoV IgM/IgG antibody in human serum, plasma or whole blood in vitro. Coronavirus belongs to the genus Coronavirus of the familyCoronaviridaein systematic classification. It is an enveloped positive-sense single-stranded RNA virus, with a diameter of about 80-120nm. Its genetic material is the largest among all RNA viruses, and it only infects humans, rats, pigs, cats, dogs and bird vertebrates. A variant of Coronavirus is the pathogen that causes SARS and belongs to RNA viruses.

[Storage conditions and shelf life] The kit shall be stored at 2~30℃ and is valid for 12 months. After unpacking the aluminum foil bag, please use it as soon as possible.

More Less

Product category: Diagnostic rapid tests

COVID-19 (SARS-CoV-2) Antigen Test Kit

Product Features:

  • Fast: The result is available in 20 mins
  • Early: Identifies acute or early infection
  • Convenient: No need for instrument and fewer steps to get the result

More Less

Product category: Diagnostic rapid tests

Mobile Shelter PCR Lab

From the beginning of 2020, the novel coronavirus, which has ravaged the whole world, has caused more than 10 million people to be infected, while the nucleic acid test in the PCR laboratory is the best way to confirm the infection of the novel coronavirus. In response to a public cry for testing of various medical institutions, the CDC, and third-party labs on COVID-19, PCR, combining with previous experience of PCR laboratory construction, we have developed a "Mobile shelter PCR Lab" to solve the problems caused by the fact that medical institutions at all levels and countries cannot be rebuilt due to limited site, neither will be constructed in a short period of time, avoid various adverse factors occurred for temporary construction, achieve rapid deployment, and provide a strong testing environment support for medical institutions in various countries and regions to quickly acquire nucleic acid testing capacity.

More Less

Product category: Diagnostic rapid tests

PT1000 Blood Gas Analyzer

This blood gas analyzer (PT1000) is used together with the blood gas testing cartridge produced by our company for the quantitative detection in vitro of the respiratory function, metabolic function and acid-base balance of the patient. There are 10 measurement parameters and 23 calculation parameters.

More Less

Product category: Diagnostic rapid tests

QFT9000 Dry Fluorescence Immunoassay Analyzer

QFT9000 Dry Fluorescence Immunoassay Analyzer is used for interpretation of the reagent kits produced by our company, as well as clinical quantitative testing of analyte in whole blood, serum and plasma samples from human body. There are 14 testing items now including 8 cardiac markers, 3 inflammatory markers, 2 cardiovascular disease risk predictors and 1 reproductive health indicator.

More Less

Product category: Diagnostic rapid tests

CF10 Chemiluminescence Immunoassay Analyzer

CF10 Chemiluminescence Immunoassay Analyzer uses magnetic particle chemiluminescence method, which is used in conjunction with the reagent kits produced by our company. It is clinically used for quantitative detection of analytes in human whole blood, serum and plasma samples. The analyzer is used in conjunction with the disposable TIP head designed by the company.

More Less

Company news



22 Oct 2020

She Power from eDiagnosis

On October 22nd, sponsored by the Provincial Woman's Federation and the Provincial Science and Technology Department, the "Hubei Phoenix Plan - She Strength - 100 Female Science and Technology Innovation Talent" announcement and symposium was held in Wuhan. Dr. Lili Chen, Chairman of Wuhan Easydiagnosis Biomedicine Co., Ltd. and Dr. Ying Wang, co-founder of Wuhan Easydiagnosis Biomedicine Co., Ltd both won the title of "Hubei Province 100 Outstanding Female Scientific and Technological Innovation Talent". Dr. Chen Lili attended the meeting as an outstanding representative and shared her experience.

The Chairman of eDiagnosis, Dr. Lili Chen, and co-founder of eDiagnosis, Dr. Ying Wang, are the typical academic entrepreneurs. After graduating from Tongji Medical College of Huazhong University of Science and Technology, they worked as clinicans at Tongji Hospital of Huazhong University of Science and Technolog. After that, they went to Germany for further study and became friends at Heidelberg University. The two doctors then went to Boston University and Tulane University for their postdoctoral research.

In 2008, they entered the Wuhan International Student Entrepreneurship Park Incubator and founded eDiagnosis, writing a different entrepreneurial landscape with their unique female intelligence and tenacity. Wuhan Easydiagnosis Biomedicine Co., Ltd was listed on the Shenzhen Stock Exchange on July 10, 2018, with the stock code 002932.

Attending the meeting on behalf of the Provincial Women's Federation, Li Shuyong expressed her warm congratulations to the honored female scientific and technological innovation talents, and paid high respects and sincere greetings to the female scientific and technological workers who have been working in the frontline of scientific research  over the time.

She hopes that the female scientific and technological workers will seize the policy opportunities that the central and provincial party committees have paid unprecedented attention to technological innovation, seize the development opportunities that revitalization of Hubei is supported by science and technology after the epidemic, give full play to the advantages of Hubei's science and education resources, and take up the sacred mission given by the times, steadfast implementation of the innovation-driven development strategy, daring innovation and work hard in their respective fields, and strive to achieve new and greater breakthroughs in core technologies in key areas.

She emphasized that the female scientific and technological workers must be supported by the spirit of scientists, strengthen their patriotism, enhance their innovation capabilities, persevere unremittingly, and be indifferent to fame and fortune, and continue to march towards the breadth and depth of science and technology, and demonstrate women's deeds in Hubei's innovation-driven development.

She requested that Women's Federations at all levels should establish contact with female scientific and technological talents, listen to their voices, reflect their opinions, and solve their problems, be the "mothers" of female scientific and technological workers.

More Less

21 Aug 2020

The Shining Moment of ediagnosis in the 2020 China Hospital Information Network Conference(CHINC)

From 21 to 23 August 2020, hosted by the Institute of Hospital Administration of the National Health Commission and organized by the "China Digital Medicine" magazine, the 2020 China Hospital Information Network Conference(CHINC) with the theme of "New Situation, New Technology, New Development" opened as scheduled under the normalization of epidemic prevention and control in China.

ediagnosis brought one-stop solution for emergency and critical care and instant diagnostic products (CF10 Chemiluminescence platform, PT1000 blood gas analysis platform, QMT8000 POCT platform, EV12 Mobile electrocardiograph)

The opening ceremony of the conference was hosted by Ye Quanfu, director of the Institute of Hospital Administration of the National Health Commission. The guests attending the opening ceremony included Li Lanjuan, Academician of the Chinese Academy of Engineering, Gu Xiaosong, Academician of the Chinese Academy of Engineering, Liu Wenxian, Deputy Director of the Planning Development and Informationization Department of the National Health Commission, Zhuang Ning, Deputy Director of the Department of System Reform of the National Health Commission, Hu Ruirong, Deputy Director of the Medical Policy and Administration Authority , Lan Qiing, deputy director of Jiangsu Provincial Health Commission, and Wang Jing, deputy chief of Nanjing Health Commission.

                        ediagnosis Integrated treatment solution of emergency and critical care
During the conference, ediagnosis presented the participants with the integrated treatment solution of emergency and critical care, include emergency care pre-inspection and triage system, chest pain center, stroke center, trauma center and integrated information platform. Our scenario-based product demonstration sessions and wonderful explanation given by product managers on site attracted many colleagues in the medical and health industry to come to communicate and consult.

                                       Integration Platform of Emergency and Critical Care  
Provides hospitals with integrated emergency care management based on cloud services IOT+SaaS, and achieve the closed-loop and traceable management of the entire process of pre-hospital , in-hospital and post-hospital care of the emergency department. The in-hospital module of the platform starts with emergency department pre-inspection and triage, which can be connected to the information systems of the five centers to record the treatment process of patients with multiple diseases, the quality control of the process in each center, the direct data reporting, and the final quality control and KPI statistical analysis of the center data.

                                    Emergency Department pre-inspection and triage System
In accordance with the "Guiding Principles for the Priority Classification of Emergency Patients" and the "Guidelines for the Construction and Management of Emergency Departments (Trial)", combined with the built-in knowledge base, assist the triage nurses to quickly identify patients who need emergency care immediately and reduce potential safety hazards during waiting and treatment. In addition, in conjunction with the "Implementation Opinions on Further Normalizing the Scientific and Precise Prevention and Control of the Novel Coronavirus Pneumonia Epidemic", the system supports the preliminary screening of fever patients by checking the health code, measuring body temperature and taking scales.

                                       Integration Information Platform of Chest Pain Center
ediagnosis provides integrated services of hardware and software for the chest pain center. The chest pain center software is a highly integrated software system in the construction of the chest pain center. The process software integrates all standard actions for chest pain patients during treatment, and the hardware data is automatically accessed to control the process of generating data, enable automatic data collection and data traceability in the reviewing process, prevent data fraud and loss, and enables real-time data analysis and quality management.

                                         Integration Information Platform of Stroke Center
ediagnosis’ "Integration Information Platform of Stroke", relying on key technologies such as the internet of things, cloud computing, artificial intelligence and big data analysis, based on policies that benefit the people such as hierarchical diagnosis and treatment, two-way referral, clinical pathways, and green channels, together the Integration Information Platform of Stroke enables the entire process of prevention, control and quality control management of critically ill patients, and opened up a VIP treatment channel from the patient to the specialist team, early detection, early treatment, and early recovery, build a bridge of life for patients to be healthy.

                                 Integration Information Platform for Trauma Emergency
Through the intelligent ambulance system, the hospital trauma emergency system, the remote consultation management system and the data platform, the patient can be intelligently matched to a hospital according to the severity and symptoms, the location and distance during the onset treatment of the patient, and provide pre-hospital emergency diagnosis and treatment services, seamlessly connect the pre-hospital emergency to the green passage in the hospital.

The 2020 CHINC conference is the first industrial event for medical Informatization after the epidemic. ediagnosis has proved that we are a professional one-stop service provider for emergency and critical care. We can provide professional services from certification consulting, informational construction, point of care testing and project operation. ediagnosis is committed to the construction of smart medical ecosystem, we are oriented by customers’ needs and provides comprehensive solutions combines medical informatization and in vitro diagnostic products.

More Less

About us

Company portrait

Wuhan EasyDiagnosis Biomedicine Co., Ltd, was founded in 2008 and is located at the National Biological Industry Base of Bio-Lake in Wuhan Optical Valley. As a new high-tech enterprise specializing in products related to in vitro diagnostic reagents and auxiliary apparatuses (POCT/molecular diagnosis/chemiluminescence/blood gas analysis etc.), Wuhan EasyDiagnosis is playing a leading role in Chinese domestic high through-put POCT products and serves as a prominent enterprise in the IVD industry. With our businesses covering more than 5,000 medical institutes in China and our sales network covering more than 35 countries and regions in Asia, Europe, South Africa, Africa, etc., Wuhan EasyDiagnosis is now a listed company (Shenzhen Stock Exchange) with the stock code of 002932. During the combat against COVID-19, Wuhan EasyDiagnosis successfully developed COVID-19 SARS-CoV-2 Nucleic Acid Test Kit and registered with NMPA in March. Now, the COVID-19 SARS-CoV-2 Nucleic Acid Test Kit, Nucleic Acid Extraction Kit, COVID-19 SARS-CoV-2 IgG/IgM Antibody Test Kit, Blood Gas Analyzer from Wuhan EasyDiagnosis has received EU CE marking, and there are more than 25 of our products are qualified for overseas sale.

Company data

Sales volume 50-99 Mio US $
Number of employees 500-999
Area of business
  • Imaging and diagnostics / medical equipment & devices
  • Diagnostics
  • IT systems and IT solutions
  • Medical Services and Publications